Company intelligence / Profile preview

Inclinix-PMG Holdings

Wilmington, North Carolina, United States

Ownership: Private
Development stage: Other

Overview

Inclinix-PMG Holdings was formed in June 2012 from the merger of Inclinix, Inc., a clinical trial enrollment CRO, and PMG Research, an integrated site network, to provide comprehensive clinical trial enrollment and site services for the biotech, pharmaceutical, and medical device sectors. Their offerings included accelerated site activation and patient recruitment. The company operated primarily in the eastern US, with global reach through enrollment managers. No therapeutic pipeline or clinical results are reported, as their focus was on service rather than drug development.

Industry: Contract Research Organization

Beyond the preview

Go deeper on Inclinix-PMG Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inclinix-PMG Holdings.

Explore the full profile